Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026
Exact Sciences Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,247 | 3,247 | 2,759 | 2,500 | 2,084 | 1,767 |
Revenue Growth | 17.69% | 17.69% | 10.37% | 19.93% | 17.95% | 18.49% |
Gross Profit Gross Profit Growth | 2,263 | 2,263 | 1,919 | 1,762 | 1,423 | 1,308 |
Operating Income Operating Income Growth | -150.12 | -150.12 | -191.79 | -308.84 | -634.16 | -710.57 |
Net Income Net Income Growth | -207.95 | -207.95 | -1,029 | -204.15 | -623.51 | -595.63 |
Earnings Per Share EPS Growth | -1.10 | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Screening Medicare Parts B & C Screening Medicare Parts B & C Growth | 955.08 | 955.08 | 776.16 | 701.4 | 545.46 | 438.65 |
Screening Commercial Screening Commercial Growth | 1,323 | 1,323 | 1,118 | 992.24 | 743.24 | 569.94 |
Screening Other Service Screening Other Service Growth | 251.58 | 251.58 | 209.38 | 171.06 | 136.01 | 53.72 |
Precision Oncology Medicare Parts B & C Precision Oncology Medicare Parts B & C Growth | 196.47 | 196.47 | 187.95 | 188.69 | 197.33 | 197.39 |
Precision Oncology Commercial Precision Oncology Commercial Growth | 196.17 | 196.17 | 190.6 | 181.32 | 177.52 | 180.18 |
Precision Oncology International Precision Oncology International Growth | 223.84 | 223.84 | 189.09 | 153.28 | 117.74 | 109.91 |
Precision Oncology Other Service Precision Oncology Other Service Growth | 100.64 | 100.64 | 87.36 | 105.83 | 108.91 | 74.19 |
Revenue (Total) Revenue (Total) Growth | 3,247 | 3,247 | 2,759 | 2,500 | 2,084 | 1,767 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 964.71 | 964.71 | 1,038 | 777.64 | 632.06 | 1,030 |
Total Debt Total Debt Growth | 2,535 | 2,535 | 2,776 | 2,567 | 2,457 | 2,401 |
Net Cash (Debt) Net Cash Growth | -1,570 | -1,570 | -1,738 | -1,789 | -1,825 | -1,370 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.32 | -8.32 | -9.43 | -9.93 | -10.35 | -8.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 491.44 | 491.44 | 210.54 | 156.12 | -223.56 | -102.24 |
Capital Expenditures CapEx Growth | -134.66 | -134.66 | -135.99 | -124.19 | -214.46 | -135.77 |
Free Cash Flow Free Cash Flow Growth | 356.78 | 356.78 | 74.55 | 31.93 | -438.02 | -238 |
Free Cash Flow Growth | 378.60% | 378.60% | 133.48% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.69% | 69.69% | 69.55% | 70.49% | 68.27% | 74.04% |
Operating Margin | -4.62% | -4.62% | -6.95% | -12.35% | -30.43% | -40.21% |
Pretax Margin | -6.28% | -6.28% | -37.56% | -8.07% | -30.35% | -47.68% |
Profit Margin | -6.40% | -6.40% | -37.29% | -8.17% | -29.92% | -33.71% |
FCF Margin | 10.99% | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 120.45 | - | - | - | - |
P/FCF Ratio | - | 54.02 | 139.50 | 419.03 | - | - |
PS Ratio | - | 5.94 | 3.77 | 5.35 | 4.22 | 7.59 |